Detection of Soluble ST2 in Human Follicular Fluid and Luteinized Granulosa Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Southcombe, Jennifer H ^a   Lédée, Nathalie ^b   d'Hauterive, Sophie Perrier ^c   Turner, Karen ^a,d   Child, Tim ^a,d   Snider, James V ^e   Redman, Christopher W G ^a   Sargent, Ian L ^a   Granne, Ingrid ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Critical Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 33; NAFARELIN ACETATE; PROTEIN; RECOMBINANT FOLLITROPIN; SOLUBLE ST2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; EMBRYO; EMBRYO TRANSFER; EX VIVO STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GRANULOSA CELL; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE RETRIEVAL; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE FLUID; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; CELLS, CULTURED; EMBRYO, MAMMALIAN; FEMALE; FOLLICULAR FLUID; GENE EXPRESSION; GRANULOSA CELLS; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; INTERLEUKINS; LUTEINIZATION; MALE; OOCYTES; PREGNANCY; RECEPTORS, CELL SURFACE; REPRODUCTIVE TECHNIQUES, ASSISTED; SOLUBILITY; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 84883763860     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074385     Document Type: Article

References (29)

1. Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, et al. (2009) Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 7: 40.
2. Brannstrom M, Norman RJ, (1993) Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 8: 1762-1775.
3. Sarapik A, Velthut A, Haller-Kikkatalo K, Faure GC, Bene MC, et al. (2012) Follicular Proinflammatory Cytokines and Chemokines as Markers of IVF Success. Clinical & Developmental Immunology: Article ID 606459.
4. Ledee N, Gridelet V, Ravet S, Jouan C, Gaspard O, et al. (2013) Impact of follicular G-CSF quantification on subsequent embryo transfer decisions: a proof of concept study. Hum Reprod 28: 406-413.
5. Gerard N, Caillaud M, Martoriati A, Goudet G, Lalmanach AC, (2004) The interleukin-1 system and female reproduction. J Endocrinol 180: 203-212.
6. Hurwitz A, Loukides J, Ricciarelli E, Botero L, Katz E, et al. (1992) Human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist. J Clin Invest 89: 1746-1754.
7. Gery I, Waksman BH, (1972) Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med 136: 143-155.
8. March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, et al. (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315: 641-647.
9. Khan SA, Schmidt K, Hallin P, Di Pauli R, De Geyter C, et al. (1988) Human testis cytosol and ovarian follicular fluid contain high amounts of interleukin-1-like factor(s). Mol Cell Endocrinol 58: 221-230.
10. Mendoza C, Ruiz-Requena E, Ortega E, Cremades N, Martinez F, et al. (2002) Follicular fluid markers of oocyte developmental potential. Hum Reprod 17: 1017-1022.
11. de los Santos MJ, Anderson DJ, Racowsky C, Simon C, Hill JA, (1998) Expression of interleukin-1 system genes in human gametes. Biol Reprod 59: 1419-1424.
12. Gutman G, Soussan-Gutman L, Malcov M, Lessing JB, Amit A, et al. (2004) Interleukin-18 is high in the serum of IVF pregnancies with ovarian hyperstimulation syndrome. Am J Reprod Immunol 51: 381-384.
13. Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Kuchler AM, (2009) Interleukin-33- cytokine of dual function or novel alarmin? Trends Immunol 30: 227-233.
14. Bianchi ME, (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5.
15. Xu D, Chan WL, Leung BP, Huang F, Wheeler R, et al. (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187: 787-794.
16. Sattler S, Smits HH, Xu D, Huang FP, (2013) The Evolutionary Role of the IL-33/ST2 System in Host Immune Defence. Arch Immunol Ther Exp (Warsz) 61: 107-117.
17. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
18. Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, et al. (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20: 1019-1030.
19. Gillibert-Duplantier J, Duthey B, Sisirak V, Salaun D, Gargi T, et al. (2011) Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis. Oncogene 31: 3516-3524.
20. Takezako N, Hayakawa M, Hayakawa H, Aoki S, Yanagisawa K, et al. (2006) ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells. Biochem Biophys Res Commun 341: 425-432.
21. Granne I, Southcombe JH, Snider JV, Tannetta DS, Child T, et al. (2011) ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS One 6: e24463.
22. Topping V, Romero R, Than NG, Tarca AL, Xu Z, et al. (2013) Interleukin-33 in the human placenta. J Matern Fetal Neonatal Med 26: 327-338.
23. Salker MS, Nautiyal J, Steel JH, Webster Z, Sucurovic S, et al. (2012) Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS One 7: e52252.
24. Tominaga S, (1989) A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 258: 301-304.
25. Ledee N, Frydman R, Osipova A, Taieb J, Gallot V, et al. (2011) Levels of follicular G-CSF and interleukin-15 appear as noninvasive biomarkers of subsequent successful birth in modified natural in vitro fertilization/intracytoplasmic sperm injection cycles. Fertility and Sterility 95: 94-98.
26. Ledee N, Lombroso R, Lombardelli L, Selva J, Dubanchet S, et al. (2008) Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor. Hum Reprod 23: 2001-2009.
27. Ledee N, Munaut C, Serazin V, d'Hauterive SP, Lombardelli L, et al. (2010) Performance evaluation of microbead and ELISA assays for follicular G-CSF: a non-invasive biomarker of oocyte developmental competence for embryo implantation. Journal of Reproductive Immunology 86: 126-132.
28. Salmassi A, Schmutzler AG, Huang L, Hedderich J, Jonat W, et al. (2004) Detection of granulocyte colony-stimulating factor and its receptor in human follicular luteinized granulosa cells. Fertility and Sterility 81Suppl 1: 786-791.
29. Yoo SW, Savchev S, Sergott L, Rezai T, Lopez MF, et al. (2011) A large network of interconnected signaling pathways in human ovarian follicles is supported by the gene expression activity of the granulosa cells. Reprod Sci 18: 476-484.